Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triapine + Cisplatin + Radiation in Cervical or Vaginal Cancer
NCT02466971Phase 3Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- May 2016
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of triapine in Cervical Cancer (CC), vaginal cancer, sponsored by National Cancer Institute. Started May 2016; status: active, not recruiting.
02
Drugs
triapine
03
Conditions
Cervical Cancer (CC)vaginal cancer
Beyond the preview
Go deeper on NCT02466971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466971.